Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)

ClinicalTrials.gov ID: NCT02971007

Public ClinicalTrials.gov record NCT02971007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 3:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)

Study identification

NCT ID
NCT02971007
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Matinas BioPharma Nanotechnologies, Inc.
Industry
Enrollment
137 participants

Conditions and interventions

Interventions

  • Oral Encochleated Amphotericin B (CAMB) Drug
  • Fluconazole Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2016
Primary completion
Apr 30, 2017
Completion
Apr 30, 2017
Last update posted
Nov 1, 2018

2016 – 2017

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
Alabama Clinical Therapeutics Birmingham Alabama 35205
Precision Trials, LLC Phoenix Arizona 85032
National Research Institute - Wilshire Los Angeles California 90057
South Florida Medical Research Aventura Florida 33180
Neostart Corporation dba AGA Clinical Trials Hialeah Florida 33012
Altus Research Lake Worth Florida 33461
Advanced Research Institute Inc New Port Richey Florida 34653
Healthcare Clinical Data, Inc. North Miami Florida 33161
Clinical Research of West Florida - Tampa Tampa Florida 33603
Visions Clinical Research Wellington Florida 33414
Mt. Vernon Clinical Research - Wake Research Atlanta Georgia 30328
Brighton Clinical Research Associates Norcross Georgia 30092
Medpharmics Metairie Louisiana 70006
New England Center for Clinical Research, Inc. Fall River Massachusetts 02720
Lawrence OB/GYN Lawrenceville New Jersey 08648
ProHEALTH Care Associates, LLC - Suffolk OB-GYN Port Jefferson New York 11777
PMG Research of Salisbury, LLC. Salisbury North Carolina 28144
PMG Research of Wilmington, LLC Wilmington North Carolina 28401
Complete Health Care for Women Columbus Ohio 43231
Study Center Columbus Ohio 43231
Jackson Clinic Jackson Tennessee 38305
Clinical Trials of Texas, Inc. San Antonio Texas 78229
Tidewater Clinical Research, Inc. Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02971007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2018 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02971007 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →